• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人参皂苷化合物 K 可抑制肝癌的转移生长,其与核因子-κB p65 的易位和基质金属蛋白酶-2/9 的减少有关。

Ginsenoside compound K attenuates metastatic growth of hepatocellular carcinoma, which is associated with the translocation of nuclear factor-κB p65 and reduction of matrix metalloproteinase-2/9.

机构信息

Research and Development Center for Plant Medicine and Plant Drugs, Xiamen Overseas Chinese Subtropical , Plant Introduction Garden, Xiamen, PR China.

出版信息

Planta Med. 2011 Mar;77(5):428-33. doi: 10.1055/s-0030-1250454. Epub 2010 Oct 26.

DOI:10.1055/s-0030-1250454
PMID:20979019
Abstract

The intestinal metabolite of ginseng saponin, compound K (CK), has various chemopreventive and chemotherapeutic activities, including anti-tumor activity. However, the functional mechanisms through which CK attenuates metastatic growth in hepatocellular carcinoma (HCC) remain unclear. Here, using multiple IN VITRO and IN VIVO models, we reported that CK strongly attenuated colony formation, adhesion, and invasion of HCC cells IN VITRO and dramatically inhibited spontaneous HCC metastatic growth IN VIVO. At the molecular level, immunofluorescence and Western blotting analysis confirmed that inhibition of metastatic growth of HCC induced by CK treatment caused a time-dependent decrease in nuclear NF- κB p65 and a concomitant increase in cytosolic NF- κB p65, indicating that CK suppressed the activation of the NF- κB pathway. Meanwhile, our study showed that the inhibition of matrix metalloproteinase2/9 (MMP2/9) expression caused by CK treatment was associated with NF- κB p65 nuclear export. Taken together, our results not only revealed that NF- κB p65 nuclear export and the reduction of MMP2/9 expression were associated with the metastatic inhibition induced by CK, but also suggested that CK may become a potential cytotoxic drug in the prevention and treatment of HCC.

摘要

人参皂苷的肠道代谢产物,化合物 K(CK),具有多种化学预防和化学治疗活性,包括抗肿瘤活性。然而,CK 减轻肝细胞癌(HCC)转移生长的功能机制尚不清楚。在这里,我们使用多种体外和体内模型报告说,CK 强烈减弱 HCC 细胞的集落形成、黏附和侵袭能力,并且显著抑制 HCC 自发性转移生长。在分子水平上,免疫荧光和 Western blot 分析证实,CK 处理抑制 HCC 转移生长导致核 NF-κB p65 的时间依赖性减少,同时胞质 NF-κB p65 增加,表明 CK 抑制 NF-κB 途径的激活。同时,我们的研究表明,CK 处理抑制基质金属蛋白酶 2/9(MMP2/9)的表达与 NF-κB p65 核输出有关。总之,我们的结果不仅揭示了 NF-κB p65 核输出和 MMP2/9 表达的减少与 CK 诱导的转移抑制有关,而且表明 CK 可能成为预防和治疗 HCC 的潜在细胞毒性药物。

相似文献

1
Ginsenoside compound K attenuates metastatic growth of hepatocellular carcinoma, which is associated with the translocation of nuclear factor-κB p65 and reduction of matrix metalloproteinase-2/9.人参皂苷化合物 K 可抑制肝癌的转移生长,其与核因子-κB p65 的易位和基质金属蛋白酶-2/9 的减少有关。
Planta Med. 2011 Mar;77(5):428-33. doi: 10.1055/s-0030-1250454. Epub 2010 Oct 26.
2
Intestinal metabolite compound K of ginseng saponin potently attenuates metastatic growth of hepatocellular carcinoma by augmenting apoptosis via a Bid-mediated mitochondrial pathway.人参皂苷肠道代谢物化合物 K 通过 Bid 介导的线粒体途径增强细胞凋亡来强力抑制肝癌转移生长。
J Agric Food Chem. 2010 Dec 22;58(24):12753-60. doi: 10.1021/jf103814f. Epub 2010 Dec 1.
3
Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.甲萘醌四烯甲萘醌,一种维生素K2类似物,通过抑制核因子κB激活来抑制细胞周期蛋白D1的表达,从而抑制肝癌细胞的生长。
Clin Cancer Res. 2007 Apr 1;13(7):2236-45. doi: 10.1158/1078-0432.CCR-06-2308.
4
Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.骨桥蛋白的下调通过诱导细胞凋亡抑制肝细胞癌的生长和转移。
Gastroenterology. 2008 Sep;135(3):956-68. doi: 10.1053/j.gastro.2008.05.025. Epub 2008 May 7.
5
Antrodia cinnamomea fruiting bodies extract suppresses the invasive potential of human liver cancer cell line PLC/PRF/5 through inhibition of nuclear factor kappaB pathway.樟芝子实体提取物通过抑制核因子κB通路抑制人肝癌细胞系PLC/PRF/5的侵袭潜能。
Food Chem Toxicol. 2007 Jul;45(7):1249-57. doi: 10.1016/j.fct.2007.01.005. Epub 2007 Jan 17.
6
The role of NF-kappaB in hepatocellular carcinoma cell.核因子κB在肝癌细胞中的作用。
Chin Med J (Engl). 2003 May;116(5):747-52.
7
Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.甘露糖介导的PA-MSHA通过EGFR/Akt/IκBβ/NF-κB途径对肝癌侵袭和转移的抑制作用。
Liver Int. 2015 Apr;35(4):1416-29. doi: 10.1111/liv.12644. Epub 2014 Aug 21.
8
Morin regulates the expression of NF-kappaB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma.桑色素调节二乙基亚硝胺诱导的大鼠肝细胞癌中NF-κB-p65、COX-2和基质金属蛋白酶的表达。
Chem Biol Interact. 2009 Aug 14;180(3):353-9. doi: 10.1016/j.cbi.2009.02.004. Epub 2009 Feb 21.
9
Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB.染料木黄酮增强三氧化二砷对人肝癌细胞的作用: Akt 和核因子-κB 的作用。
Cancer Lett. 2011 Feb 1;301(1):75-84. doi: 10.1016/j.canlet.2010.10.022.
10
Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma.紫草素,一种源自中国植物的萘醌,通过活性氧诱导肝癌细胞凋亡:肝癌治疗的新方法。
Free Radic Biol Med. 2011 Dec 15;51(12):2259-71. doi: 10.1016/j.freeradbiomed.2011.09.018. Epub 2011 Sep 22.

引用本文的文献

1
A Narrative Review: Immunometabolic Interactions of Host-Gut Microbiota and Botanical Active Ingredients in Gastrointestinal Cancers.综述:宿主-肠道微生物群与胃肠道癌症植物活性成分的免疫代谢相互作用。
Int J Mol Sci. 2024 Aug 22;25(16):9096. doi: 10.3390/ijms25169096.
2
Mechanism Research and Application for Ginsenosides in the Treatment of Hepatocellular Carcinoma.人参皂苷治疗肝细胞癌的作用机制研究及应用。
Biomed Res Int. 2023 Nov 16;2023:7214037. doi: 10.1155/2023/7214037. eCollection 2023.
3
Functional Mechanism of Ginsenoside Compound K on Tumor Growth and Metastasis.
人参皂苷Compound K 对肿瘤生长和转移的作用机制。
Integr Cancer Ther. 2022 Jan-Dec;21:15347354221101203. doi: 10.1177/15347354221101203.
4
A narrative review of the pharmacology of ginsenoside compound K.人参皂苷Compound K的药理学叙述性综述。
Ann Transl Med. 2022 Feb;10(4):234. doi: 10.21037/atm-22-501.
5
Ginsenoside CK Inhibits Hypoxia-Induced Epithelial-Mesenchymal Transformation through the HIF-1α/NF-κB Feedback Pathway in Hepatocellular Carcinoma.人参皂苷CK通过缺氧诱导因子-1α/核因子-κB反馈通路抑制肝癌细胞缺氧诱导的上皮-间质转化
Foods. 2021 May 26;10(6):1195. doi: 10.3390/foods10061195.
6
Anti-Metastatic and Anti-Inflammatory Effects of Matrix Metalloproteinase Inhibition by Ginsenosides.人参皂苷抑制基质金属蛋白酶的抗转移和抗炎作用
Biomedicines. 2021 Feb 17;9(2):198. doi: 10.3390/biomedicines9020198.
7
The lncRNA suppresses cervical cancer cell growth .长链非编码RNA抑制宫颈癌细胞生长。
Open Med (Wars). 2020 Nov 29;15(1):1184-1192. doi: 10.1515/med-2020-0241. eCollection 2020.
8
Ginsenoside compound K inhibits nuclear factor-kappa B by targeting Annexin A2.人参皂苷化合物K通过靶向膜联蛋白A2抑制核因子-κB。
J Ginseng Res. 2019 Jul;43(3):452-459. doi: 10.1016/j.jgr.2018.04.002. Epub 2018 Apr 21.
9
Fermented ginseng, GBCK25, ameliorates steatosis and inflammation in nonalcoholic steatohepatitis model.发酵人参GBCK25可改善非酒精性脂肪性肝炎模型中的脂肪变性和炎症。
J Ginseng Res. 2019 Apr;43(2):196-208. doi: 10.1016/j.jgr.2017.10.002. Epub 2017 Oct 21.
10
Preparation of ginsenoside compound-K mixed micelles with improved retention and antitumor efficacy.制备保留和抗肿瘤效果更好的人参皂苷Compound-K 混合胶束。
Int J Nanomedicine. 2018 Jul 3;13:3827-3838. doi: 10.2147/IJN.S167529. eCollection 2018.